Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of thalidomide in treating patients who have
relapsed chronic lymphocytic leukemia. Thalidomide may stop the growth of chronic lymphocytic
leukemia by stopping blood flow to the tumor.